Show simple item record

Repression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine

dc.contributor.authorSÖNMEZ, MEHMET
dc.contributor.authorYucel, Burcu
dc.date.accessioned2021-03-02T22:57:59Z
dc.date.available2021-03-02T22:57:59Z
dc.date.issued2018
dc.identifier.citationYucel B., SÖNMEZ M., "Repression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine", HEMATOLOGY, cilt.23, sa.6, ss.330-336, 2018
dc.identifier.issn1024-5332
dc.identifier.othervv_1032021
dc.identifier.otherav_0faea276-3d74-4a57-bd39-9cb3fd3342cf
dc.identifier.urihttp://hdl.handle.net/20.500.12627/16080
dc.identifier.urihttps://doi.org/10.1080/10245332.2017.1402454
dc.description.abstractObjectives: Leukemia is a group of bone marrow cancers and drug resistance is one of the challenges in treatment. Caffeic acid phenethyl ester's (CAPE's) anti-proliferative and apoptotic properties have been reported in leukemia cell lines. However, CAPE's effect on drug resistance and cellular metabolism is still unknown. Thus, in this study, we aimed to explore CAPE's effect on drug resistance and oxidative phosphorylation (oxphos).
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleRepression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine
dc.typeMakale
dc.relation.journalHEMATOLOGY
dc.contributor.departmentKaradeniz Teknik Üniversitesi , ,
dc.identifier.volume23
dc.identifier.issue6
dc.identifier.startpage330
dc.identifier.endpage336
dc.contributor.firstauthorID249226


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record